Zalfa, F.; Perrone, M.G.; Ferorelli, S.; Laera, L.; Pierri, C.L.; Tolomeo, A.; Dimiccoli, V.; Perrone, G.; De Grassi, A.; Scilimati, A.
Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma. Cancers 2022, 14, 3764.
https://doi.org/10.3390/cancers14153764
AMA Style
Zalfa F, Perrone MG, Ferorelli S, Laera L, Pierri CL, Tolomeo A, Dimiccoli V, Perrone G, De Grassi A, Scilimati A.
Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma. Cancers. 2022; 14(15):3764.
https://doi.org/10.3390/cancers14153764
Chicago/Turabian Style
Zalfa, Francesca, Maria Grazia Perrone, Savina Ferorelli, Luna Laera, Ciro Leonardo Pierri, Anna Tolomeo, Vincenzo Dimiccoli, Giuseppe Perrone, Anna De Grassi, and Antonio Scilimati.
2022. "Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma" Cancers 14, no. 15: 3764.
https://doi.org/10.3390/cancers14153764
APA Style
Zalfa, F., Perrone, M. G., Ferorelli, S., Laera, L., Pierri, C. L., Tolomeo, A., Dimiccoli, V., Perrone, G., De Grassi, A., & Scilimati, A.
(2022). Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma. Cancers, 14(15), 3764.
https://doi.org/10.3390/cancers14153764